PPT-Prevention of Recurrent Stroke: An Evidence-Based

Approach Korinne Novak APRN CNP Michelle Ullery DNP APRN CNP Uche Amajuoyi APRN CNP Mark Ringo DNP APRN CNP April 15 th 2016 1 Recognize risk factors for recurrent stroke 2 Apply current guidelines to manage risk factors for recurrent stroke in the subacute and primary care setting. Branko. N . Huisa. M.D.. Assistant Professor of Neurology. UNM Stroke Center. THE END!. CHANGABLE. . Blood pressure. Diabetes Mellitus. . Hyperlipidemia. . Atrial. fibrillation. Nicotine. Drug abuse. Presented by: Carrie Miller, MPH. . Ahmed . Alquthami, MD, MHSA. Introduction. Hypertension & . Stroke. Background. Pathophysiology. Significance. Descriptive Epidemiology. Causes. Prevention and control measures. Goals of Presentation. What is a stroke?. Types of stroke. Warning signs of stroke. Why did I have a stroke?. Are there treatments for stroke?. How can I prevent a stroke?. What Is a Stroke?. Interruption of normal blood flow to the brain. November 6, 2017. Maureen Perkins. Project Officer & Public Health Analyst. Maternal and Child Health Bureau (MCHB). Health Resources and Services Administration (HRSA). Helga Luest. Project Director, National Bullying Prevention Initiative & StopBullying.gov. The Art and Science of Prevention. MHRSB LUCAS COUNTY. BIENNIAL PREVENTION CONFERENCE. Lourdes University. Sylvania, Ohio. Friday, December 1, 2017. William O. Livisay, LSW. W. Osborne Group. Owner/Consultant. Ganesh Asaithambi, MD. John . Nasseff. Neuroscience Specialty Clinic. 11/8/18. Disclosures. No relevant financial or competing interests. Objectives. Discuss current burden of stroke and TIA. Review acute evaluations for patients presenting with acute stroke symptoms. Epidemiology, Pathophysiology, Diagnosis and Follow-up for Patients with Unknown Stroke Etiology. Stroke as a Health care Issue in the U.S.. ≈795,000,000 . new or recurrent strokes. . yearly. 87% . European Stroke Organisation Conference, Lyon. Guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. Jesse Dawson, Yannick . 89 non-cardioembolic stroke detected by rapid platelet function analyzer Jose C NAVARRO MD MSc , Annabelle Y LAO MD , Maricar P YUMUL MD , Maria Leticia C ARAULLO MD , Johnny K LOKIN MD , Aleja -24- Primary prevention refers to those activities de sign ed to prevent the onset of a disease or condition. The most effective way to prevent stroke is, of course, to avoid the risk factors th Stroke is the second leading cause of death and a leading cause of disability worldwide. This invaluable reference provides clinicians caring for stroke patients with ready access to the optimal evidence for best practice in stroke prevention, acute stroke treatment, and stroke recovery. Now an edited volume, the editors and authors, many of whom are members of the Cochrane Stroke Review Group, describe all available medical, endovascular, and surgical treatments the rationale for using them and the strength of the evidence for their safety and effectiveness. New chapters cover key, rapidly advancing therapeutic topics, including prehospital stroke care and regionalized stroke systems, endovascular reperfusion therapy, and electrical and magnetic brain stimulation to enhance recovery. This is an essential resource for clinicians translating into practice the many dramatic advances that have been made in the treatment and prevention of stroke, and suggesting the most appropriate interventions. GPhC. National NHS Liaison. Since 2013 . pharmacists from . Interface Clinical Services have reviewed nearly . 300,000. AF patients across more than . 2,000. . sites. Interface have been supporting . By Cole Smith PharmD Candidate 2021. Outline:. Background on Coagulopathy and Cancer. Current VTE treatment guideline recommendations. Important trials influencing current recommendations. New Caravaggio Study (03/2020). Michela Rosso. CANCER AND STROKE. CANCER and VTE. LMWH . for at least 3 to 6 months . has . been the standard of care in treating cancer-associated . VTE [4]. .. Historically. , . LMWH . have been preferred for cancer-associated VTE .